Personal Products & Services
Compare Stocks
4 / 10Stock Comparison
MRM vs AMZN vs MSFT vs XPOF
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Retail
Software - Infrastructure
Leisure
MRM vs AMZN vs MSFT vs XPOF — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Personal Products & Services | Specialty Retail | Software - Infrastructure | Leisure |
| Market Cap | $6M | $2.92T | $3.13T | $244M |
| Revenue (TTM) | $11.91B | $742.78B | $318.27B | $299M |
| Net Income (TTM) | $615M | $90.80B | $125.22B | $-34M |
| Gross Margin | 26.4% | 50.6% | 68.3% | 83.2% |
| Operating Margin | -0.9% | 11.5% | 46.8% | 7.8% |
| Forward P/E | 6.4x | 34.8x | 25.3x | 10.9x |
| Total Debt | $3.96B | $152.99B | $112.18B | $525M |
| Cash & Equiv. | $329M | $86.81B | $30.24B | $46M |
MRM vs AMZN vs MSFT vs XPOF — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| MEDIROM Healthcare … (MRM) | 100 | 15.7 | -84.3% |
| Amazon.com, Inc. (AMZN) | 100 | 163.0 | +63.0% |
| Microsoft Corporati… (MSFT) | 100 | 147.7 | +47.7% |
| Xponential Fitness,… (XPOF) | 100 | 55.8 | -44.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MRM vs AMZN vs MSFT vs XPOF
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MRM is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 21.5%, EPS growth 28.1%, 3Y rev CAGR 15.3%
- PEG 0.13 vs MSFT's 1.35
- 21.5% revenue growth vs XPOF's -1.7%
- Lower P/E (6.4x vs 25.3x), PEG 0.13 vs 1.35
AMZN plays a supporting role in this comparison — it may shine differently against other peers.
MSFT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 19 yrs, beta 0.89, yield 0.8%
- 7.9% 10Y total return vs AMZN's 7.0%
- Lower volatility, beta 0.89, Low D/E 32.7%, current ratio 1.35x
- Beta 0.89, yield 0.8%, current ratio 1.35x
XPOF lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 21.5% revenue growth vs XPOF's -1.7% | |
| Value | Lower P/E (6.4x vs 25.3x), PEG 0.13 vs 1.35 | |
| Quality / Margins | 39.3% margin vs XPOF's -11.3% | |
| Stability / Safety | Beta 0.89 vs XPOF's 1.94 | |
| Dividends | 0.8% yield, 19-year raise streak, vs XPOF's 2.5%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +47.9% vs XPOF's -22.6% | |
| Efficiency (ROA) | 19.2% ROA vs XPOF's -9.5%, ROIC 24.9% vs 75.0% |
MRM vs AMZN vs MSFT vs XPOF — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MRM vs AMZN vs MSFT vs XPOF — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSFT leads in 1 of 6 categories
XPOF leads 1 • AMZN leads 1 • MRM leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSFT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 2486.6x XPOF's $299M. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to XPOF's -11.3%. On growth, MSFT holds the edge at +18.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $11.9B | $742.8B | $318.3B | $299M |
| EBITDAEarnings before interest/tax | $338M | $155.9B | $192.6B | $35M |
| Net IncomeAfter-tax profit | $615M | $90.8B | $125.2B | -$34M |
| Free Cash FlowCash after capex | -$2.0B | -$2.5B | $72.9B | -$3M |
| Gross MarginGross profit ÷ Revenue | +26.4% | +50.6% | +68.3% | +83.2% |
| Operating MarginEBIT ÷ Revenue | -0.9% | +11.5% | +46.8% | +7.8% |
| Net MarginNet income ÷ Revenue | +5.2% | +12.2% | +39.3% | -11.3% |
| FCF MarginFCF ÷ Revenue | -16.8% | -0.3% | +22.9% | -1.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -99.4% | +16.6% | +18.3% | -21.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +99.5% | +74.8% | +23.4% | +79.1% |
Valuation Metrics
XPOF leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 6.4x trailing earnings, MRM trades at a 83% valuation discount to AMZN's 37.8x P/E. Adjusting for growth (PEG ratio), MRM offers better value at 0.13x vs MSFT's 1.64x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $6M | $2.92T | $3.13T | $244M |
| Enterprise ValueMkt cap + debt − cash | $29M | $2.98T | $3.21T | $723M |
| Trailing P/EPrice ÷ TTM EPS | 6.36x | 37.82x | 30.86x | -4.45x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 34.77x | 25.34x | 10.90x |
| PEG RatioP/E ÷ EPS growth rate | 0.13x | 1.35x | 1.64x | — |
| EV / EBITDAEnterprise value multiple | 16.75x | 20.47x | 19.72x | 7.89x |
| Price / SalesMarket cap ÷ Revenue | 0.11x | 4.07x | 11.10x | 0.78x |
| Price / BookPrice ÷ Book value/share | 0.89x | 7.14x | 9.15x | — |
| Price / FCFMarket cap ÷ FCF | — | 378.98x | 43.66x | 9.86x |
Profitability & Efficiency
Evenly matched — MSFT and XPOF each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
MRM delivers a 2.4% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $23 for AMZN. MSFT carries lower financial leverage with a 0.33x debt-to-equity ratio, signaling a more conservative balance sheet compared to MRM's 3.33x. On the Piotroski fundamental quality scale (0–9), MRM scores 6/9 vs XPOF's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.4% | +23.3% | +33.1% | — |
| ROA (TTM)Return on assets | +11.8% | +11.5% | +19.2% | -9.5% |
| ROICReturn on invested capital | -0.3% | +14.7% | +24.9% | +75.0% |
| ROCEReturn on capital employed | -0.5% | +15.3% | +29.7% | +30.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 3.33x | 0.37x | 0.33x | — |
| Net DebtTotal debt minus cash | $3.6B | $66.2B | $81.9B | $479M |
| Cash & Equiv.Liquid assets | $329M | $86.8B | $30.2B | $46M |
| Total DebtShort + long-term debt | $4.0B | $153.0B | $112.2B | $525M |
| Interest CoverageEBIT ÷ Interest expense | 0.56x | 39.96x | 55.65x | -0.24x |
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSFT five years ago would be worth $17,246 today (with dividends reinvested), compared to $1,176 for MRM. Over the past 12 months, MRM leads with a +47.9% total return vs XPOF's -22.6%. The 3-year compound annual growth rate (CAGR) favors AMZN at 36.8% vs MRM's -41.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -40.8% | +19.7% | -10.8% | -18.5% |
| 1-Year ReturnPast 12 months | +47.9% | +43.7% | -2.1% | -22.6% |
| 3-Year ReturnCumulative with dividends | -80.0% | +156.2% | +39.5% | -77.4% |
| 5-Year ReturnCumulative with dividends | -88.2% | +64.8% | +72.5% | -46.6% |
| 10-Year ReturnCumulative with dividends | -92.3% | +697.8% | +787.7% | -46.6% |
| CAGR (3Y)Annualised 3-year return | -41.5% | +36.8% | +11.7% | -39.1% |
Risk & Volatility
Evenly matched — MRM and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
MRM is the less volatile stock with a -0.54 beta — it tends to amplify market swings less than XPOF's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.3% from its 52-week high vs MRM's 26.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.54x | 1.51x | 0.89x | 1.94x |
| 52-Week HighHighest price in past year | $4.45 | $278.56 | $555.45 | $11.14 |
| 52-Week LowLowest price in past year | $0.72 | $185.01 | $356.28 | $3.83 |
| % of 52W HighCurrent price vs 52-week peak | +26.1% | +97.3% | +75.8% | +58.7% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 81.1 | 54.0 | 48.4 |
| Avg Volume (50D)Average daily shares traded | 378K | 45.5M | 32.5M | 626K |
Analyst Outlook
Evenly matched — MSFT and XPOF each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AMZN as "Buy", MSFT as "Buy", XPOF as "Buy". Consensus price targets imply 31.1% upside for MSFT (target: $552) vs 13.1% for AMZN (target: $307). For income investors, XPOF offers the higher dividend yield at 2.50% vs MSFT's 0.77%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $306.77 | $551.75 | $8.00 |
| # AnalystsCovering analysts | — | 94 | 81 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.8% | +2.5% |
| Dividend StreakConsecutive years of raises | — | — | 19 | 0 |
| Dividend / ShareAnnual DPS | — | — | $3.23 | $0.16 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.6% | 0.0% |
MSFT leads in 1 of 6 categories (Income & Cash Flow). XPOF leads in 1 (Valuation Metrics). 3 tied.
MRM vs AMZN vs MSFT vs XPOF: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MRM or AMZN or MSFT or XPOF a better buy right now?
For growth investors, MEDIROM Healthcare Technologies Inc.
(MRM) is the stronger pick with 21. 5% revenue growth year-over-year, versus -1. 7% for Xponential Fitness, Inc. (XPOF). MEDIROM Healthcare Technologies Inc. (MRM) offers the better valuation at 6. 4x trailing P/E, making it the more compelling value choice. Analysts rate Amazon. com, Inc. (AMZN) a "Buy" — based on 94 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MRM or AMZN or MSFT or XPOF?
On trailing P/E, MEDIROM Healthcare Technologies Inc.
(MRM) is the cheapest at 6. 4x versus Amazon. com, Inc. at 37. 8x. On forward P/E, Xponential Fitness, Inc. is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Amazon. com, Inc. wins at 1. 24x versus Microsoft Corporation's 1. 35x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — MRM or AMZN or MSFT or XPOF?
Over the past 5 years, Microsoft Corporation (MSFT) delivered a total return of +72.
5%, compared to -88. 2% for MEDIROM Healthcare Technologies Inc. (MRM). Over 10 years, the gap is even starker: MSFT returned +787. 7% versus MRM's -92. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MRM or AMZN or MSFT or XPOF?
By beta (market sensitivity over 5 years), MEDIROM Healthcare Technologies Inc.
(MRM) is the lower-risk stock at -0. 54β versus Xponential Fitness, Inc. 's 1. 94β — meaning XPOF is approximately -456% more volatile than MRM relative to the S&P 500. On balance sheet safety, Microsoft Corporation (MSFT) carries a lower debt/equity ratio of 33% versus 3% for MEDIROM Healthcare Technologies Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MRM or AMZN or MSFT or XPOF?
By revenue growth (latest reported year), MEDIROM Healthcare Technologies Inc.
(MRM) is pulling ahead at 21. 5% versus -1. 7% for Xponential Fitness, Inc. (XPOF). On earnings-per-share growth, the picture is similar: Xponential Fitness, Inc. grew EPS 35. 2% year-over-year, compared to 15. 6% for Microsoft Corporation. Over a 3-year CAGR, MRM leads at 15. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MRM or AMZN or MSFT or XPOF?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus -10. 7% for Xponential Fitness, Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus -0. 2% for MRM. At the gross margin level — before operating expenses — XPOF leads at 75. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MRM or AMZN or MSFT or XPOF more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Amazon. com, Inc. (AMZN) is the more undervalued stock at a PEG of 1. 24x versus Microsoft Corporation's 1. 35x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Xponential Fitness, Inc. (XPOF) trades at 10. 9x forward P/E versus 34. 8x for Amazon. com, Inc. — 23. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MSFT: 31. 1% to $551. 75.
08Which pays a better dividend — MRM or AMZN or MSFT or XPOF?
In this comparison, XPOF (2.
5% yield), MSFT (0. 8% yield) pay a dividend. MRM, AMZN do not pay a meaningful dividend and should not be held primarily for income.
09Is MRM or AMZN or MSFT or XPOF better for a retirement portfolio?
For long-horizon retirement investors, MEDIROM Healthcare Technologies Inc.
(MRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 54)). Xponential Fitness, Inc. (XPOF) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MRM: -92. 3%, XPOF: -46. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MRM and AMZN and MSFT and XPOF?
These companies operate in different sectors (MRM (Consumer Cyclical) and AMZN (Consumer Cyclical) and MSFT (Technology) and XPOF (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MRM is a small-cap high-growth stock; AMZN is a mega-cap quality compounder stock; MSFT is a mega-cap quality compounder stock; XPOF is a small-cap quality compounder stock. MSFT, XPOF pay a dividend while MRM, AMZN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.